Grace Jiang

Dr. Grace Jiang serves as Vice President, Head of Regulatory Affairs at Amunix. She has two decades of protein research and biotech experience including 15 years career at Amgen Inc. She is an experienced regulatory professional with expertise in immune-oncology across all stages of drug development. She is also a cross-functional leader with broad experience leading teams and initiatives within Regulatory Affairs, Manufacturing and Quality, most recently at Gracell Biotechnologies and prior to that at Amgen.

Prior to Amunix, she served as the Head of Regulatory developing new generation of CAR T cell therapy at Gracell Biotechnologies. While at Amgen, she played key roles in the successful global registration of Blincyto and Kyprolis in multiple regions. She led the crossfunctional China Taskforce that executed the Amgen/BeiGene collaboration and significantly expanded Amgen’s portfolio in China.

Beyond her professional career, Dr. Jiang is a passionate leader supporting the early career development community. She served on the board of the local chapter of the Association for Women in Science and Technology (AWIS) for multiple years and was a speaker for multiple career development events at USC, UCLA and UCR.

Dr. Jiang holds a PhD in Chemistry from the University of California at Riverside and a B.S. from Peking University, School of Pharmacy.